Age: 70.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Fatigue, Vaccination site movement impairment, Vaccination site swelling
Clinical narrative: could not raise arm; swelling; fatigue; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of JOINT RANGE OF MOTION DECREASED (could not raise arm), SWELLING (swelling) and FATIGUE (fatigue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 032L0A) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Lupus syndrome.    The patient's past medical history included Tobacco user (2 packs per day 1963-2006) from 1963 to 2006, Back surgery (Back surgeries) in 1985, Hysterectomy in 1985, Hiatal hernia repair in 1985, Brain stem stroke from 09-Feb-2006 to 2010, Cataract (Both eyes) in 2014, Abstains from alcohol since an unknown date, Neuropathy, Nerve damage (Having numbness on legs and throbbing pain on feet) and German measles. Concurrent medical conditions included Thyroid disorder NOS (unspecified), Lupus erythematosus systemic, Congestive heart failure, Migraine, Increased blood pressure, Stomach pain and Drug allergy (codeine allergy manifested by swelling of lips and eyelids/throat closes/itchiness). Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA) for Blood pressure high, LACTULOSE for Bowel movement irregularity, ACETYLSALICYLIC ACID (ASPIRIN CUPAL [ACETYLSALICYLIC ACID]) and FUROSEMIDE (LASIX [FUROSEMIDE]) for Congestive heart failure, ERYTHROMYCIN for Digestion impaired, ROPINIROLE HYDROCHLORIDE (REQUIP) for Legs restless, BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET) for Migraine, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) and TRAMADOL HYDROCHLORIDE (ULTRAMED [TRAMADOL HYDROCHLORIDE]) for Pain, DICYCLOVERINE HYDROCHLORIDE (BENTYL) and ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for Stomach ache, FUSION PLUS for Supplementation therapy, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroiditis, unspecified.   In 2019, the patient ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to 40 mg. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (unknown route) at an unspecified dose. On 07-Jan-2021, the patient experienced JOINT RANGE OF MOTION DECREASED (could not raise arm), SWELLING (swelling) and FATIGUE (fatigue). In January 2021, JOINT RANGE OF MOTION DECREASED (could not raise arm), SWELLING (swelling) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   2019 The patient experienced off label use and injection site stinging while using Humira.  25-Mar-2021 It is reported that the patient experienced wrong injection technique and device issues in regards to Humira injection.